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Abstract
Introduction—Hispanics/Latinos (henceforth, Latinos) are the largest minority group in the U.S. 
With growing health disparities among this group, the highest burden remains among sexual and 
gender minority Latinos. Differences regarding sexual orientation have not been fully explored 
within this group using national representative samples. This study analyzed sexual and behavioral 
health disparities associated with sexual minority status among Latinos in the U.S.
Methods—The study included data from 5,598 Latino adults who participated in the 2001–2014 
waves of the National Health and Nutrition Examination Survey. Data analysis was conducted in 
2016. Bivariate and multivariable logistic regression analyses examined the prevalence of HIV, 
sexually transmitted infections, mental health problems, cigarette smoking, and alcohol/illicit drug 
use among sexual minorities and heterosexual Latino adults. Sexual minorities were defined as 
“gay, lesbian, and bisexual” (GLB) and “other” non-heterosexual groups.
Results—GLB Latinos reported higher prevalence of mental health problems and cigarette 
smoking compared with heterosexuals. After adjusting for covariates, GLB Latinos had greater 
odds of testing positive for HIV, lifetime diagnosis of sexually transmitted infections, poor mental 
health outcomes, cigarette smoking (including lifetime and current smoking status), and illicit 
drug use than heterosexuals.
Conclusions—The disproportionate impact of health disparities among Latinos varies 
significantly by sexual orientation, with GLB individuals facing elevated prevalence. In particular, 
elevated odds for HIV/sexually transmitted infections, mental health problems, smoking, and illicit 
substance use were found. Further research, including longitudinal studies to understand the 
trajectories of risks, is needed to identify intervention opportunities in this population.
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INTRODUCTION
Hispanics/Latinos (henceforth, Latinos) are among the largest and fastest growing minority 
groups in the U.S., comprising 17% of the population in 2014.1 Though significant health 
disparities in sexual and behavioral health persist among Latinos,2–4 emerging studies 
suggest that sexual minorities bear the brunt of these disparities.5,6 Studies have identified 
factors, such as poverty, that contribute to health disparities for Latinos as a whole,7,8 but 
few investigations have explored risk factors and outcomes specifically for sexual minorities 
within this population. In response to numerous calls for efforts to better understand health 
disparities among sexual minorities within racial/ethnic minority groups,9–11 this paper 
sought to examine various sexual and behavioral health outcomes by sexual orientation 
among Latinos using nationally representative data.
METHODS
Study Population
This study used data from the 2001–2014 waves of the National Health and Nutrition 
Examination Survey, a nationally representative sample of non-institutionalized, civilian 
populations in the U.S.12 Analyses were restricted to participants with data on all covariates 
and to those who completed the clinical examination phase providing biospecimen data.
Measures
Sociodemographic variables included age, gender, education, employment, marital status, 
place of birth, citizenship, income, health insurance status, and access to a regular healthcare 
provider.
Sexual orientation was assessed using the following question: Do you think of yourself as 
heterosexual or straight (attracted to the opposite sex); homosexual or gay/lesbian (attracted 
to the same sex); bisexual (attracted to men and women); something else; or you're not sure? 
Participants were characterized as “heterosexual” if they self-identified as such. The 
remaining participants were divided into two categories: “gay, lesbian, and bisexual” (GLB) 
for individuals who selected these options, and “other” for those who self-identified as 
something else or not sure.
Participants provided blood and urine specimens to test for the presence of the HIV 
antibody, chlamydia, herpes simplex virus type 2, and the hepatitis C antibody. Participants 
further reported lifetime gonorrhea, chlamydia, herpes, and genital warts diagnoses, as well 
as lifetime HIV testing.
Participants reported the number of days of poor mental health during the past 30 days 
(stress, depression, and emotional problems).
Participants reported whether they had consumed more than five alcoholic drinks in 1 day 
during the past year, whether they had smoked more than 100 cigarettes during their 
lifetime, current smoking status, and any prior drug use.
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Statistical Analysis
All analyses were conducted using Stata, version 14.1. Weighted percentages and 95% CIs 
were calculated for sociodemographic characteristics, biologically assessed HIV/sexually 
transmitted infections (STIs), self-reported HIV/STI testing, and other psychological and 
behavioral health variables, separated by sexual orientation. Sample weights were assigned 
to achieve estimates that could approximate the entire sampling frame; weighting accounted 
for nonresponse, oversampling of specific subgroups, post-survey stratification, and 
sampling error.12
The GLB and other non-heterosexuals were initially compared with heterosexual 
participants on the weighted prevalence of each variable using chi-square test or one-way 
ANOVA, and then via multivariable logistic regression analyses to assess each health 
outcome, adjusting for sociodemographic variables. A 15-day cut off was applied for 
number of poor mental health days during the past month.13 Poisson regressions were 
utilized for dependent variables with count data (number of drinking and heavy drinking 
days) because of skewed distributions. AORs and 95% CIs were reported for logistic 
regressions, and adjusted incidence rate ratios for Poisson regressions; heterosexuals served 
as the reference group for all models. All analyses were executed using the svy prefix 
command to incorporate the National Health and Nutrition Examination Survey sampling 
weights and account for the complex sampling design.
RESULTS
Table 1 presents weighted descriptive statistics and comparisons between heterosexuals, 
GLB participants, and other non-heterosexuals. Compared with heterosexuals, GLB 
participants were more likely to have completed college, less likely to be married, more 
likely to have been born in the U.S., more likely to be U.S. citizens, and more likely to earn 
< $20,000. Those who identified their sexuality as “something else” or “not sure” were less 
likely to have completed college, be employed, be married, have been U.S.-born, be U.S. 
citizens, and more likely to earn < $20,000 compared with heterosexuals.
Weighted prevalence estimates and group comparisons for HIV/STIs are presented in Table 
2. Compared with heterosexuals, GLB participants were more likely to test HIV positive and 
to have ever been told they had STIs, chlamydia, and genital warts. Table 3 presents data 
from multivariable analyses with outcomes adjusted for age, education, employment, marital 
status, place of birth, citizenship status, and family income. GLB participants and other non-
heterosexuals were both more likely to test HIV positive; GLB participants were also more 
likely to have previously tested positive for STIs, including gonorrhea.
In bivariate analyses, GLB participants reported the poorest mental health, followed by 
heterosexuals and other non-heterosexuals (Table 2). Similar patterns held for lifetime 
consumption of ≥ 100 cigarettes, current smoking, lifetime marijuana use, and cocaine/
heroin/ amphetamines (i.e., highest rates among GLB participants, lowest among other non-
heterosexuals). In multi-variable analyses, GLB participants were more likely than 
heterosexuals to have experienced ≥ 15 days of poor mental health over the past 30 days. 
GLB participants were also more likely to have smoked ≥ 100 cigarettes in their lifetime; to 
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smoke currently; and to have used marijuana, cocaine, heroin, or methamphetamine; other 
non-heterosexuals were less likely than heterosexuals to report each of these outcomes.
DISCUSSION
This is one of the first studies using nationally representative survey data to analyze the 
health disparities associated with sexual minority status among Latinos. GLB Latinos report 
substantially worse sexual and behavioral health outcomes than their heterosexual 
counterparts. Disparities in mental health, smoking patterns, and illicit drug use are 
consistent with findings elsewhere in analysis of community or state-level data.14–17 
Smoking rates in this sample are higher than those documented in prior studies with sexual 
minorities and the general population.18,19 Several factors potentially contribute to health 
disparities among GLB Latinos, including discrimination in care,20,21 lack of access to 
appropriate care,22 language barriers and documentation status,23,24 and delayed general and 
HIV care due to stigma.25,26
Alarming health disparities found in this investigation indicate the need for targeted efforts. 
Screening GLB Latinos for HIV/STIs, mental health, tobacco use, and illicit drug use at 
each point of contact with health providers is highly recommended. These results also 
underscore the need for culturally appropriate interventions responsive to these and other 
relevant psychosocial conditions. Results highlight the importance of measuring outcomes 
by sexual orientation and support numerous calls to incorporate sexual orientation measures 
into both epidemiologic and intervention research.27
Limitations
There were several limitations to this study. This study only included adults aged 20–49 
years for whom data on key variables were systematically collected (e.g., herpes simplex 
virus type 2). In regression analyses, wide CIs might suggest instability in effect sizes. 
Sample size concerns prohibited comparisons among subsets of GLB participants. In 
addition, this study relied solely on identity labels as a measure for sexual orientation.
CONCLUSIONS
The effects of sexual minority status among Latinos must be considered in addressing health 
disparities. These findings suggest that greater public health efforts are needed to enhance 
health, close research gaps, and eliminate disparities that disproportionately affect racial/
ethnic minorities, sexual minorities, and individuals who occupy both of these marginalized 
statuses.
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1.
45
 (0
.74
, 2
.86
)
0.
28
0.
29
 (0
.13
, 0
.62
)
<
0.
01
 
N
ev
er
 s
m
o
ke
r
(ba
se)
(ba
se)
 
Ev
er
 u
se
d 
m
ar
iju
an
a o
r h
ash
ish
 (2
00
5–
20
14
 on
ly)
2.
18
 (1
.17
, 4
.07
)
0.
02
0.
26
 (0
.10
, 0
.64
)
<
0.
01
 
Ev
er
 u
se
d 
co
ca
in
e/
he
ro
in
/m
et
ha
m
ph
et
am
in
e 
(20
05
–2
01
4 o
nly
)
1.
93
 (1
.00
, 3
.72
)
0.
04
9
0.
37
 (0
.14
, 0
.95
)
0.
04
 
Ev
er
 in
jec
ted
 dr
ug
s (
20
05
–2
01
4 o
nly
)
1.
19
 (0
.18
, 7
.79
)
0.
85
1.
44
 (0
.13
, 1
5.3
5)
0.
76
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N
ot
e:
 B
ol
df
ac
e 
in
di
ca
te
s s
ta
tis
tic
al
 si
gn
ifi
ca
nc
e 
(p<
0.
05
). A
dju
ste
d f
ora
ge
, g
en
de
r, s
u
rv
ey
 y
ea
r, 
ed
uc
at
io
n,
 e
m
pl
oy
m
en
t, 
m
ar
ita
l s
ta
tu
s, 
pl
ac
e 
of
 b
irt
h,
 c
iti
ze
ns
hi
p 
sta
tu
s, 
an
d 
fa
m
ily
 in
co
m
e.
 D
at
a 
re
pr
es
en
te
d 
w
ei
gh
te
d 
re
su
lts
. A
 m
ul
tin
om
ia
l m
od
el
 w
as
 u
se
d 
fo
r c
ur
re
nt
 sm
ok
in
g 
sta
tu
s, 
w
ith
 “
ne
v
er
 s
m
o
ke
r”
 a
s 
th
e 
ba
se
.
a S
el
f-i
de
nt
ifi
ed
 a
s “
so
m
et
hi
ng
 e
lse
” 
or
 “
no
t s
ur
e.
”
b A
IR
R 
ba
se
d 
on
 P
oi
ss
on
 re
gr
es
sio
n.
A
IR
R,
 a
dju
ste
d i
nc
ide
nc
e r
ate
 ra
tio
; G
LB
, g
ay
,
 
le
sb
ia
n,
 o
r b
ise
x
u
al
; H
SV
-
2,
 h
er
pe
s s
im
pl
ex
 v
iru
s t
yp
e 
2;
 N
H
A
N
ES
, N
at
io
na
l H
ea
lth
 a
nd
 N
ut
rit
io
n 
Ex
am
in
at
io
n 
Su
rv
ey
; S
TI
, s
ex
u
al
ly
 tr
an
sm
itt
ed
 in
fe
ct
io
n.
N
o 
fin
an
ci
al
 d
isc
lo
su
re
s w
er
e 
re
po
rte
d 
by
 th
e 
au
th
or
s o
f t
hi
s p
ap
er
.
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